Related Experiment Video
Updated: Jun 6, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
[Development and Implementation of HPV Vaccination]
1Department of Pathology, University of Cambridge.
Abstract:
Cervical cancer is primarily caused by infection with the human papillomavirus (HPV) and has become a disease that can be effectively prevented through vaccination and cervical screening. This review briefly summarises the virological background, development process, and actual implementation of HPV prophylactic vaccines, which are a key pillar of prevention. With prophylactic HPV vaccination and cervical screening, the incidence of HPV-related cancers is expected to decrease significantly. The ultimate goal is to achieve a society with "One Less Worry" about HPV infections and the cancers they cause.
More Related Videos
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Preventive Healthcare Services
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...